Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.98 Min. order: 1 piece ★★★★★ 4.3 (174 reviews) Sold : Login>>
Novo Nosedives on Underwhelming CagriSema Phase III Weight-Loss Data US$ 25.70 Min. order: 1 piece ★★★★★ 4.1 (153 reviews) Sold : Login>>
Novo's Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial US$ 21.01 Min. order: 1 piece ★★★★★ 4.8 (134 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.3 (224 reviews) Sold : Login>>
Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.2 (167 reviews) Sold : Login>>
Peptide Tools & Guides – Atlas Nutrition US$ 21.65 Min. order: 1 piece ★★★★★ 4.0 (241 reviews) Sold : Login>>